Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

v3.7.0.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) - 3 months ended Mar. 31, 2017 - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2016 $ (45,525) $ 4 $ (293) $ (45,236)
Beginning balance, shares at Dec. 31, 2016   2,620,803    
Repurchase of common stock (56)   (56)  
Repurchase of common stock, shares   (7,500)    
Common stock issued to convertible note payable holders 2,016   2,016  
Common stock issued to convertible note payable holders, shares   165,000    
Issuance of warrants 549   549  
Modification of warrants 371   371  
Beneficial conversion feature 554   554  
Stock-based compensation expense 125   125  
Issuance of restricted stock 0 $ 0 0 0
Issuance of restricted stocks, shares   1,500    
Accretion of redeemable convertible preferred stock (1,073)     (1,073)
Net loss (5,847)     (5,847)
Ending balance at Mar. 31, 2017 $ (48,886) $ 4 $ 3,266 $ (52,156)
Ending balance, shares at Mar. 31, 2017   2,779,803